CUBIST PHARMACEUTICALS INC's ticker is and the CUSIP is 229678AD9. A total of 40 filers reported holding CUBIST PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $9,698,000 | -52.8% | 4,159,000 | -50.4% | 0.02% | +4.3% |
| Q2 2014 | $20,558,000 | +95.8% | 8,378,000 | +104.1% | 0.02% | -4.2% |
| Q1 2014 | $10,499,000 | +44.0% | 4,105,000 | +37.1% | 0.02% | +50.0% |
| Q4 2013 | $7,290,000 | -28.3% | 2,994,000 | -33.7% | 0.02% | -30.4% |
| Q3 2013 | $10,163,000 | -51.5% | 4,513,000 | -62.2% | 0.02% | -52.1% |
| Q2 2013 | $20,935,000 | – | 11,933,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sage Capital Management, LLC | 2,200,000 | $3,861,000 | 4.03% |
| GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $4,392,000 | 3.78% |
| Raven Rock Credit Master Fund L.P. | 1,250,000 | $2,193,000 | 3.72% |
| CAMDEN ASSET MANAGEMENT L P /CA | 39,100,000 | $68,498,000 | 3.66% |
| Mohican Financial Management, LLC | 8,850,000 | $15,526,000 | 3.53% |
| Polar Asset Management Partners Inc. | 25,000,000 | $43,885,000 | 2.33% |
| SYMPHONY ASSET MANAGEMENT LLC | 13,027,000 | $22,822,000 | 2.20% |
| BASSO CAPITAL MANAGEMENT, L.P. | 4,000,000 | $7,030,000 | 1.31% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 7,000,000 | $12,263,000 | 1.12% |
| Jabre Capital Partners S.A. | 5,000,000 | $8,781,000 | 1.10% |